European Journal of Cancer
Volume 45, Issue 1 , Pages 119-126 , January 2009

The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors

  • W.H. Heideman

      Affiliations

    • The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • N.S. Russell

      Affiliations

    • The Netherlands Cancer Institute, Department of Radiotherapy, Amsterdam, The Netherlands
    • ,
  • C. Gundy

      Affiliations

    • The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • ,
  • M.A. Rookus

      Affiliations

    • The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 20 512 2491; fax: +31 20 512 2322.
    • ,
  • D.W. Voskuil

      Affiliations

    • The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Received 18 August 2008 ,Accepted 5 September 2008.

References 

  1. WHO Europe. The challenge of obesity in the WHO European Region. WHO Europe 2005. <http://www.euro.who.int/>.
  2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591
  3. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002;20:3302–3316
  4. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20:1128–1143
  5. Goodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17:120–129
  6. Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1993;11:1418–1429
  7. Partridge AH, Burstein HJ, Winer EP. Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr. 2001;135–142
  8. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97:519–529
  9. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19:2381–2389
  10. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005;19:871–881
  11. Irwin ML, Crumley D, McTiernan A, et al. Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study. Cancer. 2003;97:1746–1757
  12. Irwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23:774–782
  13. Demark-Wahnefried W, Hars V, Conaway MR, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr. 1997;65:1495–1501
  14. Del Rio G, Zironi S, Valeriani L, et al. Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition. Breast Cancer Res Treat. 2002;73:267–273
  15. Harvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2004;83:201–210
  16. Campbell KL, Lane K, Martin AD, Gelmon KA, McKenzie DC. Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs. 2007;30:95–100
  17. Hoskin PJ, Ashley S, Yarnold JR. Weight gain after primary surgery for breast cancer – effect of tamoxifen. Breast Cancer Res Treat. 1992;22:129–132
  18. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23:1370–1378
  19. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher B. Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol. 1999;17:2659–2669
  20. Caan BJ, Emond JA, Natarajan L, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006;99:47–57
  21. Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23:5814–5830
  22. Herman DR, Ganz PA, Petersen L, Greendale GA. Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS). Breast Cancer Res Treat. 2005;93:13–23
  23. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007;105:195–207
  24. Freedman RJ, Aziz N, Albanes D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004;89:2248–2253
  25. Kumar N, Allen KA, Riccardi D, et al. Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?. Breast Cancer Res Treat. 2004;83:149–159
  26. Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer. 1991;67:1954–1959
  27. Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast J. 2007;13:258–265
  28. Saquib N, Flatt SW, Natarajan L, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat. 2007;105:177–186
  29. Gao Q, Mezei G, Nie Y, et al. Anorectic estrogen mimics leptin’s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med. 2007;13:89–94
  30. Coll AP, Farooqi IS, O’Rahilly S. The hormonal control of food intake. Cell. 2007;129:251–262
  31. Wade GN, Gray JM, Bartness TJ. Gonadal influences on adiposity. Int J Obesity. 1985;9(Suppl 1):83–92
  32. Simkin-Silverman LR, Wing RR. Weight gain during menopause. Is it inevitable or can it be prevented?. Postgrad Med. 2000;108:47–56
  33. Sternfeld B, Wang H, Quesenberry CP, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women’s Health across the Nation. Am J Epidemiol. 2004;160:912–922
  34. International Obesity Task Force. Global prevalence of adult obesity; 2008. <http://www.iotf.org/database/>.
  35. Maru S, van der Schouw YT, Gimbrere CH, Grobbee DE, Peeters PH. Body mass index and short-term weight change in relation to mortality in Dutch women after age 50 years. Am J Clin Nutr. 2004;80:231–236

PII: S0959-8049(08)00702-8

doi: 10.1016/j.ejca.2008.09.003

European Journal of Cancer
Volume 45, Issue 1 , Pages 119-126 , January 2009

Article Tools

* Image Usage & Resolution